-
-
-
-
-
-
-
JPMorgan Upgrades Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) to Neutral
-
-
-
-
-
-
-
Stem notified of NYSE noncompliance over market cap and equity
-
-
-
-
-
-
-
Wells Fargo Names Top Pick Ahead of Q3 Earnings
-
-
-
-
-
-
-
Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MS
-
-
-
-
-
-
-
SS&C Technologies shares fall on weak Q4 revenue outlook
-
-
-
-
-
-
-
KBRA Releases Research – The Forward Look—U.S. Credit Insights: Q4 2026
-
-
-
-
-
-
-
Tompkins Financial (TMP) Tops Q3 EPS by 5c
-
1,233,833 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


